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aortic aneurysm repair
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Objective: During endovascular abdominal aortic aneurysm repair (EVAR), blood is trapped in the aneurysm sac at the
moment the endograft is deployed. It is generally assumed that this blood will coagulate and evolve into an organized
thrombus. It is unknown whether this process always occurs, what its time span is, and how it influences aneurysm
shrinkage. With magnetic resonance imaging (MRI), quantitative analysis of the aneurysm sac is possible in terms of
endoleak volume as well as unorganized thrombus volume and organized thrombus volume. We investigated the presence
of unorganized thrombus in nonshrinking aneurysms years after EVAR.
Methods: Fourteen patients with a nonshrinking aneurysm without endoleak on computed tomography/computed
tomography angiography underwent MRI with a blood pool agent (gadofosveset trisodium). Precontrast T1-, precon-
trast T2-, and postcontrast T1-weighted images (3 and 30 minutes after injection) were acquired and evaluated for the
presence of endoleak. The aneurysm sac was segmented into endoleak, unorganized thrombus, and organized thrombus
by interactively thresholding the differently weighted images. The classification was visualized in real-time as a color
overlay on the MR images. The volumes of endoleak, unorganized thrombus, and organized thrombus were calculated.
Results:Median time after EVAR was 2 years (range, 1-8.2 years). The average aneurysm sac volume of the patients was
167 107 mL (mean standard deviation). Nine patients had an endoleak on the postcontrast T1-w images 30 minutes
after injection. On average, the aneurysm sac contained 78  61 mL unorganized thrombus, which corresponded to
51  21 volume-percentage, irrespective of the presence of an endoleak on the blood pool agent enhanced MRI images
(independent t-test, P  .8).
Conclusions: In our study group, half of the nonshrinking aneurysm sac contents consisted of unorganized thrombus years
after EVAR. (J Vasc Surg 2012;56:938-42.)
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cThe aneurysm size of patients after endovascular ab-
dominal aortic aneurysm repair (EVAR) is closely moni-
tored. Aneurysm shrinkage as well as the lack of aneurysm
growth usually carries a good prognosis. In case of a grow-
ing aneurysm, rupture risk is increased. Many growing
aneurysms are due to an endoleak. However, some aneu-
rysms exhibit aneurysm growth without evidence of en-
doleak on computed tomography angiography (CTA) and
delayed CT.1-3 This phenomenon has been termed endo-
tension. Different etiologies for endotension have been
proposed, such as slow flow endoleak below the detection
threshold of CTA, intermittent (eg, position-dependent)
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938ndoleak, or stent graft porosity.4 Magnetic resonance
maging (MRI) is more sensitive for endoleak than CT.5-10
low flow endoleaks and graft porosity can be diagnosed
ith MRI after injection of a blood pool contrast
gent.11-14 Images with blood pool enhancement can then
e acquired as long as 60 minutes after injection.15
Prior to EVAR, there is a large interpatient variation in
he presence of thrombus in the aneurysm and its degree of
rganization.16 During endograft deployment, a certain
mount of blood is trapped between the intra-aneurysmal
hrombus and the endograft. It is generally assumed that
his blood will coagulate and evolve into an organized
hrombus. The time span in which this occurs as well as its
nfluence on aneurysm shrinkage is unknown. The evolu-
ion of aneurysm sac contents is not monitored in the
urrent, mostly CTA-based follow-up. In contrast, with
RI, visualization of thrombus organization is possible;
norganized thrombus has a high signal intensity on T2-
eighted imaging, while thrombus organization leads to a
ecrease in signal intensity.17 The changing appearance of
he intra-aneurysmal thrombus in time has been described
y Engellau et al.18
Recently, a new method for aneurysm sac monitoring
ith MRI has been described, which combines both the
apabilities of MRI in terms of quantifying unorganized
hrombus and in terms of endoleak imaging.19We used this
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bus in nonshrinking aneurysms years after EVAR.
METHODS
Patients. Data from an institutional review board-
approved study into the use of a blood pool contrast agent
for the detection of slow flow endoleak were reviewed for
this study.11,12 Written informed consent was obtained
from all participants. Fourteen patients with a nonshrinking
aneurysm without endoleak on CT/CTAmore than 1 year
after EVAR with anMR-compatible endoprosthesis under-
went MRI with intravenous administration of a blood pool
contrast agent (gadofosveset trisodium, Vasovist; Bayer
Healthcare, Berlin, Germany). The MRI examinations
were conducted on a clinical 1.5-T MR scanner (Achieva;
Philips Healthcare, Best, The Netherlands).
MRI acquisition. Transverse precontrast T1-weighted
spin echo (repetition time [TR] 580ms; echo time [TE] 14
ms; acquisition time 5.27 minutes), precontrast T2-
weighted turbo spin echo (TR 6130 ms; TE 100 ms; echo
train length 17; acquisition time 4.30 minutes), and post-
contrast T1-weighted spin echo (as precontrast) acquisi-
tions were acquired both 3minutes (early postcontrast) and
30 minutes after injection (late postcontrast) with 3-mm
slice thickness, no slice gap, 60 slices, field of view of 270
385 mm2, a 179 256 acquisition matrix, voxel size 1.5
1.5 mm, covering the entire aortic aneurysm. A regional
saturation slab was placed on the ventral abdominal wall to
prevent ghosting artifacts from breathing. Phase-encoded
arrhythmia rejection (PEAR; Philips Healthcare) was used
to further minimize breathing artifacts.
Image analysis. Aneurysm volumes and the volumes
of the intra-aneurysmal thrombus were measured with
OsiriX (open source software, version 3.8.1, www.osirix-
viewer.com) on the CTA data, which were acquired before
EVAR. To correct for patient motion between the MRI
sequences, all images were rigidly registered to the early
postcontrast T1-w images using the Elastix software.20 As a
first step in the quantification of aneurysm sac contents, the
aneurysmal thrombus was manually segmented from the
level of the proximal attachment of the endograft to
the native aortic bifurcation; iliac aneurysms were not in-
cluded. A few voxels in the direct vicinity of the stent graft
suffered from signal loss due to susceptibility artifacts.21
These voxels were not included in the segmentation of the
aneurysm sac. Then, the aneurysm sac voxels were classified
based on the precontrast T1- and T2-weighted and late
postcontrast T1-weighted images in the categories en-
doleak, unorganized thrombus volume, or organized
thrombus volume. This was done interactively by thresh-
olding the multispectral images relative to the signal inten-
sity of fat according to the scheme shown in Table I. This
method and its interobserver agreement were described
earlier.19 To eliminate interobserver variability, two observ-
ers classified the aneurysm sac voxels in consensus in this
study. The volumes of all voxels in each category were
calculated and expressed in milliliters. tThe postcontrast images acquired 3 and 30 minutes
fter contrast injection were evaluated for the presence of
ndoleak by two experienced observers. In case of discrep-
nt ratings, a third observer decided whether endoleak was
resent.12
The amount of unorganized thrombus in patients with
nd without evidence of endoleak on postcontrast T1-w
mages was compared with the independent t-test after
ormality was assessed with the Kolmogorov-Smirnov test.
P value .05 was considered significant. Statistical anal-
sis was performed using SPSS 16.0 (SPSS, Chicago, Ill).
ESULTS
The results of the individual patients are given in Table
I. Example images are shown in Figs 1-3. The presence of
norganized thrombus was confirmed in patient 10, who
ad a large growing aneurysm containing a large volume of
norganized thrombus (Fig 1). In this patient, a CT-
uided thrombin injection was performed, which was pre-
eded by aspiration of aneurysm sac contents. Approxi-
ately 300 mL of blood was aspirated from the aneurysm
ac, confirming the presence of unorganized thrombus.22
n two patients, more than 70% of the aneurysm sac con-
isted of unorganized thrombus. The average aneurysm sac
olume of all patients was 167  107 mL. The average
norganized thrombus volume was 78  61 mL, which
orresponded to 51%  21% of aneurysm sac volume
Table III). In two patients, the aneurysm sac already had
igh signal intensity on the T1-weighted images before
ontrast injection (Fig 3). In nine patients, endoleak was
isualized on the postcontrast images 30 minutes after
njection.11,12 In patients with endoleak, the mean unor-
anized thrombus volume was 71 44 mL (52% 19% of
neurysm sac volume), which was not significantly different
rom 91 89 mL (49% 26% of aneurysm sac volume) in
atients without endoleak. The three growing aneurysms
ere larger than the stable aneurysms (303  110 mL
ompared with 130  72 mL; P  .007, independent t-
est). Mean unorganized thrombus volume in patients with
growing aneurysm was 137  112 mL (42%  29% of
neurysm sac volume) compared with 62 32 mL (53%
9% of aneurysm sac volume) in patients with a stable
neurysm (P  .4, independent t-test).
ISCUSSION
Aneurysm sac contents after EVAR naturally change in
able I. Combination of signal intensities for the
ifferent categories used for voxel classification
T1-weighted T2-weighted
T1-weighted
postcontrast
ndoleak Low Mostly high High
norganized
thrombus
Low/high High Same as
precontrast
rganized
thrombus
Low Low Lowime. Blood is trapped in the aneurysm sac during the
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late and to evolve into an organized thrombus.
An improved understanding of the evolution of aneu-
rysm sac contents may increase our insight in aneurysm size
changes and endotension. A few studies have demonstrated
the capabilities of MRI for assessment of aneurysm sac
contents. Recently, a method for quantification of aneu-
rysm sac contents with MRI has been developed. Based on
the signal intensity on T1- and T2-weighted images and
postcontrast T1-weighted images, the volumes of unorga-
nized thrombus, organized thrombus, and endoleak in the
aneurysm sac can be determined.19
We used this method in patients with nonshrinking
aneurysms without evidence of endoleak on CTA. To reach
Table II. Individual patient results
Patient Gender
Age
(years)
Preop AAA
vol (mL)
Preop thrombus
vol (mL)
T
EV
1 M 82 151 19
2 M 73 177 80
3 F 70 NA NA
4 M 81 NA NA
5 M 82 206 17
6 F 82 125 25
7 M 71 289 199
8 M 58 313 211
9 M 76 NA NA
10 M 90 413 207
11 M 76 152 66
12 M 81 175 48
13 M 62 197 0
14 M 79 180 103
EVT/Ancure (Guidant, Menlo Park, Calif); Guidant AUI, aorto-uniiliac G
Talent endoprosthesis (Medtronic Vascular, Minneapolis, Minn).
Preop AAA vol represents the total aneurysm volume (including the lumen) b
on the preoperative CTA examination. In three patients, no digital preoper
volume measured on blood pool agent enhanced MRI images 30 minutes aft
aneurysm sac volume.
Fig 1. Transverse precontrast T1-w (A), T2-w (B),
trisodium in patient with Talent endoprosthesis 1 year a
(patient 10; Table II). The aneurysm of this 90-year-old
detectable endoleak.Voxel classificationoverlays are shown
organized thrombus, and blue voxels are voxels outside the a
(B), which is yellow in (D). Unorganized thrombus volu
mL/44%; the volume of the aneurysm sac was 439 mL
aspiration of approximately 300 mL of blood from the athe highest possible sensitivity for endoleak, we used a alood pool contrast agent and acquired postcontrast im-
ges after a long delay of 30 minutes. We found no signif-
cant relation between nonorganization of thrombus and
ndoleak; however, this could represent a type II error, due
o a small number of patients.
Our results demonstrate that we do not yet fully under-
tand the evolution of aneurysm sac contents in time. A far
ower amount of unorganized thrombus would be ex-
ected after several years if the aneurysm sac merely repre-
ented an organizing thrombus. Perhaps these areas with
igh signal intensity on T2-weighted images represent a
art of the aneurysm sac that will remain fluid and may
ever lead to thrombus. The use of anticoagulant medica-
ion could play a role. All our patients used acetyl salicylic
fter
ears) Endoprosthesis
Endoleak
volume (mL)
Unorganized
thrombus (%)
Size
change
OGE 16 74 Stable
Talent 1 51 Stable
EVT/Ancure 4 62 Stable
OGE 1 63 Stable
Talent 1 8 Growth
LPGE 0 79 Stable
Talent 11 44 Stable
OGE 23 44 Stable
Guidant AUI 6 61 Stable
Talent 0 56 Growth
Talent 0 39 Stable
Talent 0 9 Stable
Talent 27 62 Growth
Talent 0 61 Stable
(Guidant); OGE, Original Excluder (W. L. Gore, Flagstaff, Ariz); Talent,
EVAR. Preop thrombus volume represents the thrombus volumemeasured
TA scan was available. The column endoleak volume represents endoleak
ction. Unorganized thrombus is given as volume percentage of nonluminal
1-w 30 minutes (C) after injection of gadofosveset
ndovascular abdominal aortic aneurysm repair (EVAR)
ent increased 23 mm in diameter during 1 year without
; yellow represents unorganized thrombus, green represents
ysm sac. A large unorganized thrombus volume is visible in
as 244 mL/56%; organized thrombus volume was 195
presence of unorganized thrombus was confirmed by
sm sac.ime a
AR (y
1.9
1.3
8.0
2.9
2.0
1.0
1.9
2.9
8.2
1.0
1.0
3.1
2.0
0.9
uidant
efore
ative Cand T
fter e
pati
in (D)
neur
me w
. Thecid (100 mg per day). Two patients used acenocoumarol.
f
t
i
h
t
i
i
f
p
o
p
i
w
g
anize
51% 
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 4 Cornelissen et al 941The unorganized thrombus volume in these two patients
was not different from the other patients.
Probably, multiple processes take place simultaneously
with buildup and break down of thrombus, leading to an
equilibrium situation of organized thrombus and unorga-
nized thrombus volume. To gain more insight in the evo-
lution of the aneurysm sac, we are currently conducting a
longitudinal study to investigate early postoperative
changes in the thrombus mass with MRI. We think the
possibility of endoleak is still not completely excluded in
the five patients in whom no endoleak was visualized.
Possibly, these patients suffer from endoleaks with different
hemodynamics, which cannot be demonstrated even with
blood pool agent enhanced MRI (eg, intermittent or
position-dependent endoleak). The possibility of occult
endoleak is supported by the observation of high signal
Fig 2. Transverse (A) precontrast T1-w, (B) T2-w, (C
contrast agent in patient 8 years after implantation of a G
(patient 9; Table II). Voxel classification overlays are sh
represents organized thrombus, and blue voxels are voxel
peripheral in the aneurysm sac more caudally. The aneur
unorganized thrombus.
Fig 3. Transverse (A) precontrast T1-w, (B) T2-w, (C
contrast agent in patient 1 year after implantation of an E
classification overlays are shown in (E), yellow represents
and blue voxels are voxels outside the aneurysm sac. The
signal intensity before injection of contrast agent. The ane
intensity on the T2-weighted images representing unorg
Table III. Summary statistics of endoleak volume, unorga
aneurysm sac volume of our patient group
Endoleak volume
Uno
Milliliters (mean  SD) 6  9 mL
Volume percentage (mean  SD) 4%  6%intensity in the aneurysm sac on T1-weighted images be- Eore contrast injection of almost the entire aneurysm sac in
wo patients. This suggests the presence of methemoglobin
n the aneurysm sac, which is a breakdown product of
emoglobin present in recently thrombosed material. Al-
ernatively, other still unknown mechanisms leading to an
ncrease in unorganized thrombus may be present (eg,
nflammatory reactions, exudation of fluid through graft
abric, or thrombus fibrinolysis). These differences in com-
osition of the aneurysm sac remain occult on CT because
f insufficient contrast resolution.
A limitation of our study is that we did not include
atients with shrinking aneurysms. To determine the clin-
cal significance of our findings, future studies in patients
ith shrinking aneurysms are advocated.
In summary, our data show that the amount of unor-
anized thrombus in the aneurysm sac several years after
-w 3 minutes, and (D) 30 minutes after injection of
t aorto-uni-iliac device with a stable aneurysm diameter
in (E), yellow represents unorganized thrombus, green
ide the aneurysm sac. This patient had a subtle endoleak
ac volume was 130 mL, of which 61% had the aspect of
-w 3 minutes, and (D) 30 minutes after injection of
er Low Permeability device (patient 6; Table II). Voxel
anized thrombus, green represents organized thrombus,
s no evidence of endoleak. The aneurysm sac had a high
sac volume was 86 mL, of which 79% had a high signal
d thrombus.
d thrombus volume, organized thrombus volume, and
zed thrombus
lume
Organized thrombus
volume Aneurysm sac volume
61 mL 83  71 mL 167  107 mL
21% 45%  24%) T1
uidan
own
s outs
ysm s) T1
xclud
unorg
re wa
urysmnize
rgani
vo
78 VAR is higher than expected. Thus, the aneurysm sac
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knowledge on the evolution of aneurysm sac contents
potentially increases the insight in aneurysm size changes.
Therefore, MRI data from larger patient numbers are
needed as well as longitudinal data on changing aneurysm
sac contents in time. These data can then serve as reference
data for patients with complicated sac behavior such as
aneurysm growth with or without detectable endoleak.
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